gip glp 1 agonist Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes Targeting GLP-1, GIP & GCG

Theyre basically the same class of drug They are not

The vasodilatory effects are certainly directly related to NO levels while the increased power output may be related to increased cellular supply of the propionate unit which when converted to succinate provides an anaplerotic energy substrate

Pharmaceutics 15 , 829 (2023)

How is Sermorelin different from Tesamorelin

ED is commonly managed with first-line treatments, including phosphodiesterase type 5 (PDE5) inhibitors (sildenafil, tadalafil, and vardenafil), which enhance nitric oxide-mediated vasodilation to facilitate erections and are effective in many diabetes patients

Acknowledgements This research was supported by Korea Drug Development Fund funded by Ministry of Science and ICT, Ministry of Trade, Industry, and Energy, and Ministry of Health and Welfare (RS-2024-00335179, Republic of Korea